Fusobacterium necrophorum

Background:

——————————————————————————
Anaerobic Gram-Negative Bacilli
——————————————————————————
>Bacteroides fragilis (most important clinically)
    [Other Bacteroides species  – less common clinically:  (B. acidifaciens, B. gracilis,
         B. oris, B. ovatus,  B. pyogenes , B. stercoris, B. vulgatus)]
>Bacteroides melaninogenicus (reclassified and split into Prevotella melaninogenica
     and Prevotella intermedia.)
>Fusobacterium necrophorum led
>Porphyromonas gingivalis

Fusobacterium:  

  • Anaerobic, Gram-negative bacteria, similar to Bacteroides.
  • Rod-shaped baccilli with pointed ends.
  • Strains of Fusobacterium contribute to several human diseases, including periodontal diseases, Lemierre’s syndrome, and topical skin ulcers.
  •  In contrast to Bacteroides species, Fusobacteria have a potent lipopolysaccharide.

 

top of page

Therapy:

Important considerations:  The choice of an agent should be based on local antimicrobial sensitivities, site of infection, cost, and comorbid conditions.   Generally, the most common agents/regimens are listed first.

Severe cases: consider combination therapy:  infections may be polymicrobial, and other organisms can mimic fusobacteriosis.   Also MIC/susceptibility testing should generally be performed for all serious infections.

  1. Metronidazole 500mg IV/PO every 6 hours
  2. Clindamycin  Usual: 600-900mg IV every 6 or 8 hours or 150 to 450mg orally every 6-8 hours
  3. Piperacillin-tazobactam (Zosyn ®)  3.375 to 4.5  grams IV q6h
  4. Imipenem 500mg IV every 6 hours [Range: 250-1000 mg q6-8h]

Disclaimer

The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user’s use of or reliance upon this material.PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read the disclaimer